Literature DB >> 24739798

Adipokines: another link between obesity and hypertension.

A R Sabbatini1, A P C de Faria1, R Modolo1, H Moreno1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24739798     DOI： 10.1038/jhh.2014.28

Source DB:  PubMed          Journal:  J Hum Hypertens        ISSN： 0950-9240            Impact factor:   3.012


× No keyword cloud information.
  9 in total

1.  Characteristics of resistant hypertension: ageing, body mass index, hyperaldosteronism, cardiac hypertrophy and vascular stiffness.

Authors:  L C Martins; V N Figueiredo; T Quinaglia; L Boer-Martins; J C Yugar-Toledo; J F V Martin; C Demacq; E Pimenta; D A Calhoun; H Moreno
Journal:  J Hum Hypertens       Date:  2010-10-07       Impact factor: 3.012

2.  Pivotal role of the mineralocorticoid receptor in corticosteroid-induced adipogenesis.

Authors:  Massimiliano Caprio; Bruno Fève; Aurélie Claës; Say Viengchareun; Marc Lombès; Maria-Christina Zennaro
Journal:  FASEB J       Date:  2007-03-23       Impact factor: 5.191

Review 3.  Adipose tissue as an endocrine organ: from theory to practice.

Authors:  Miriam Helena Fonseca-Alaniz; Julie Takada; Maria Isabel Cardoso Alonso-Vale; Fabio Bessa Lima
Journal:  J Pediatr (Rio J)       Date:  2007-11-08       Impact factor: 2.197

Review 4.  A critical review of the evidence supporting aldosterone in the etiology and its blockade in the treatment of obesity-associated hypertension.

Authors:  J B Byrd; R D Brook
Journal:  J Hum Hypertens       Date:  2013-05-23       Impact factor: 3.012

5.  High-circulating leptin levels are associated with increased blood pressure in uncontrolled resistant hypertension.

Authors:  C de Haro Moraes; V N Figueiredo; A P C de Faria; N R Barbaro; A R Sabbatini; T Quinaglia; S E Ferreira-Melo; L C Martins; C Demacq; H M Júnior
Journal:  J Hum Hypertens       Date:  2012-07-19       Impact factor: 3.012

6.  Fat cells may be the obesity-hypertension link: human adipogenic factors stimulate aldosterone secretion from adrenocortical cells.

Authors:  Monika Ehrhart-Bornstein; Karen Arakelyan; Alexander W Krug; Werner A Scherbaum; Stefan R Bornstein
Journal:  Endocr Res       Date:  2004-11       Impact factor: 1.720

7.  Deregulation of adipokines related to target organ damage on resistant hypertension.

Authors:  A R Sabbatini; A P Faria; N R Barbaro; W M Gordo; R G P Modolo; C Pinho; V Fontana; H Moreno
Journal:  J Hum Hypertens       Date:  2013-11-28       Impact factor: 3.012

8.  Hypoadiponectinemia and aldosterone excess are associated with lack of blood pressure control in subjects with resistant hypertension.

Authors:  Ana P C de Faria; Caroline Demacq; Valéria N Figueiredo; Carolina H Moraes; Rodrigo C Santos; Andréa R Sabbatini; Natália R Barbaro; Leandro Boer-Martins; Vanessa Fontana; Heitor Moreno
Journal:  Hypertens Res       Date:  2013-08-22       Impact factor: 3.872

Review 9.  Narrative review: the emerging clinical implications of the role of aldosterone in the metabolic syndrome and resistant hypertension.

Authors:  James R Sowers; Adam Whaley-Connell; Murray Epstein
Journal:  Ann Intern Med       Date:  2009-06-02       Impact factor: 25.391
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.